Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 8479501
[patent_doc_number] => 20120278908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'METHOD FOR THE DIAGNOSIS/PROGNOSIS OF AGE-RELATED MACULAR DEGENERATION'
[patent_app_type] => utility
[patent_app_number] => 13/499121
[patent_app_country] => US
[patent_app_date] => 2010-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10972
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13499121
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/499121 | METHOD FOR THE DIAGNOSIS/PROGNOSIS OF AGE-RELATED MACULAR DEGENERATION | Sep 30, 2010 | Abandoned |
Array
(
[id] => 8489528
[patent_doc_number] => 20120288935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-15
[patent_title] => '\"Click\" Nanoparticle Conjugates'
[patent_app_type] => utility
[patent_app_number] => 13/497214
[patent_app_country] => US
[patent_app_date] => 2010-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12206
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 44
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497214
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/497214 | Click" Nanoparticle Conjugates | Sep 21, 2010 | Abandoned |
Array
(
[id] => 6137402
[patent_doc_number] => 20110009570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'Preparation of polyphosphazene microspheres'
[patent_app_type] => utility
[patent_app_number] => 12/924056
[patent_app_country] => US
[patent_app_date] => 2010-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3263
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20110009570.pdf
[firstpage_image] =>[orig_patent_app_number] => 12924056
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/924056 | Preparation of polyphosphazene microspheres | Sep 19, 2010 | Abandoned |
Array
(
[id] => 10830828
[patent_doc_number] => 08858990
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-14
[patent_title] => 'Capsule of thermogenic cells for treating a metabolic disease'
[patent_app_type] => utility
[patent_app_number] => 12/884587
[patent_app_country] => US
[patent_app_date] => 2010-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 21
[patent_no_of_words] => 8419
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12884587
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/884587 | Capsule of thermogenic cells for treating a metabolic disease | Sep 16, 2010 | Issued |
Array
(
[id] => 5938448
[patent_doc_number] => 20110213288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-01
[patent_title] => 'Device And Method For Transfecting Cells For Therapeutic Uses'
[patent_app_type] => utility
[patent_app_number] => 12/884084
[patent_app_country] => US
[patent_app_date] => 2010-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 19140
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20110213288.pdf
[firstpage_image] =>[orig_patent_app_number] => 12884084
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/884084 | Device And Method For Transfecting Cells For Therapeutic Uses | Sep 15, 2010 | Abandoned |
Array
(
[id] => 6047568
[patent_doc_number] => 20110207162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'Dynamic visualization of expressed gene networks in living cells'
[patent_app_type] => utility
[patent_app_number] => 12/923256
[patent_app_country] => US
[patent_app_date] => 2010-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8045
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20110207162.pdf
[firstpage_image] =>[orig_patent_app_number] => 12923256
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/923256 | Dynamic visualization of expressed gene networks in living cells | Sep 9, 2010 | Abandoned |
Array
(
[id] => 10620541
[patent_doc_number] => 09339465
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-17
[patent_title] => 'Nucleic acid microspheres, production and delivery thereof'
[patent_app_type] => utility
[patent_app_number] => 12/878783
[patent_app_country] => US
[patent_app_date] => 2010-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 17
[patent_no_of_words] => 6915
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12878783
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/878783 | Nucleic acid microspheres, production and delivery thereof | Sep 8, 2010 | Issued |
Array
(
[id] => 8251847
[patent_doc_number] => 20120156170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-21
[patent_title] => 'DRUG COMPOSITION FOR ANGIOGENESIS THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/393062
[patent_app_country] => US
[patent_app_date] => 2010-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6510
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20120156170.pdf
[firstpage_image] =>[orig_patent_app_number] => 13393062
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/393062 | DRUG COMPOSITION FOR ANGIOGENESIS THERAPY | Aug 29, 2010 | Abandoned |
Array
(
[id] => 8264785
[patent_doc_number] => 20120164214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'LIPOSOMAL COMPOSITIONS AND USES OF SAME'
[patent_app_type] => utility
[patent_app_number] => 13/392575
[patent_app_country] => US
[patent_app_date] => 2010-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 25244
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392575
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/392575 | Liposomal compositions and uses of same | Aug 25, 2010 | Issued |
Array
(
[id] => 6402939
[patent_doc_number] => 20100305199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'THERAPEUTIC REGIMEN FOR TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/855050
[patent_app_country] => US
[patent_app_date] => 2010-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18417
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20100305199.pdf
[firstpage_image] =>[orig_patent_app_number] => 12855050
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/855050 | THERAPEUTIC REGIMEN FOR TREATING CANCER | Aug 11, 2010 | Abandoned |
Array
(
[id] => 7510903
[patent_doc_number] => 20110256625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'Liver Engrafting Cells, Assays, and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/853477
[patent_app_country] => US
[patent_app_date] => 2010-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 13128
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20110256625.pdf
[firstpage_image] =>[orig_patent_app_number] => 12853477
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/853477 | Liver engrafting cells, assays, and uses thereof | Aug 9, 2010 | Issued |
Array
(
[id] => 5969277
[patent_doc_number] => 20110150979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'METHODS FOR DIAGNOSIS, PROGNOSIS AND TREATMENT OF PRIMARY AND METASTATIC BASAL-LIKE BREAST CANCER AND OTHER CANCER TYPES'
[patent_app_type] => utility
[patent_app_number] => 12/852453
[patent_app_country] => US
[patent_app_date] => 2010-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 27686
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20110150979.pdf
[firstpage_image] =>[orig_patent_app_number] => 12852453
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/852453 | METHODS FOR DIAGNOSIS, PROGNOSIS AND TREATMENT OF PRIMARY AND METASTATIC BASAL-LIKE BREAST CANCER AND OTHER CANCER TYPES | Aug 6, 2010 | Abandoned |
Array
(
[id] => 12043467
[patent_doc_number] => 09821052
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-21
[patent_title] => 'Reverse genetics systems'
[patent_app_type] => utility
[patent_app_number] => 13/388033
[patent_app_country] => US
[patent_app_date] => 2010-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13253
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388033
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/388033 | Reverse genetics systems | Jul 29, 2010 | Issued |
Array
(
[id] => 7754836
[patent_doc_number] => 20120027861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'Nano-carrier, complex of anticancer drug and nano-carrier, pharmaceutical composition thereof, method for manufacturing the complex, and method for treating cancer by using the pharmaceutical composition'
[patent_app_type] => utility
[patent_app_number] => 12/805424
[patent_app_country] => US
[patent_app_date] => 2010-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3143
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20120027861.pdf
[firstpage_image] =>[orig_patent_app_number] => 12805424
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/805424 | Nano-carrier, complex of anticancer drug and nano-carrier, pharmaceutical composition thereof, method for manufacturing the complex, and method for treating cancer by using the pharmaceutical composition | Jul 29, 2010 | Issued |
Array
(
[id] => 8146786
[patent_doc_number] => 08163796
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2012-04-24
[patent_title] => 'Treatment of cancer by oxidation-reduction potentiation of cancerostatic dicarbonyls'
[patent_app_type] => utility
[patent_app_number] => 12/804376
[patent_app_country] => US
[patent_app_date] => 2010-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8850
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/163/08163796.pdf
[firstpage_image] =>[orig_patent_app_number] => 12804376
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/804376 | Treatment of cancer by oxidation-reduction potentiation of cancerostatic dicarbonyls | Jul 19, 2010 | Issued |
Array
(
[id] => 6478165
[patent_doc_number] => 20100285089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'Medical Devices, Drug Coatings And Methods For Maintaining The Drug Coatings Thereon'
[patent_app_type] => utility
[patent_app_number] => 12/839918
[patent_app_country] => US
[patent_app_date] => 2010-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 22105
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20100285089.pdf
[firstpage_image] =>[orig_patent_app_number] => 12839918
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/839918 | Medical Devices, Drug Coatings And Methods For Maintaining The Drug Coatings Thereon | Jul 19, 2010 | Abandoned |
Array
(
[id] => 8301039
[patent_doc_number] => 20120183596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-19
[patent_title] => 'Encapsulation of Plasmid DNA (Lipogenes) and Therapeutic Agents with Nuclear Localization Signal/Fusogenic Peptide Conjugates into Targeted Liposome Complexes'
[patent_app_type] => utility
[patent_app_number] => 12/830118
[patent_app_country] => US
[patent_app_date] => 2010-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 31315
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12830118
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/830118 | Encapsulation of Plasmid DNA (Lipogenes) and Therapeutic Agents with Nuclear Localization Signal/Fusogenic Peptide Conjugates into Targeted Liposome Complexes | Jul 1, 2010 | Abandoned |
Array
(
[id] => 6505878
[patent_doc_number] => 20100260855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'DELIVERY OF AS-OLIGONUCLEOTIDE MICROSPHERES TO INDUCE DENDRITIC CELL TOLERANCE FOR THE TREATMENT OF AUTOIMMUNE TYPE 1 DIABETES'
[patent_app_type] => utility
[patent_app_number] => 12/822774
[patent_app_country] => US
[patent_app_date] => 2010-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3713
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20100260855.pdf
[firstpage_image] =>[orig_patent_app_number] => 12822774
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/822774 | Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes | Jun 23, 2010 | Issued |
Array
(
[id] => 6007084
[patent_doc_number] => 20110059115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'ANTIBODY COMPOSITION EXHIBITING CELLULAR CYTOTOXICTY DUE TO GLYCOSYLATION'
[patent_app_type] => utility
[patent_app_number] => 12/818735
[patent_app_country] => US
[patent_app_date] => 2010-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 77382
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20110059115.pdf
[firstpage_image] =>[orig_patent_app_number] => 12818735
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/818735 | Antibody composition exhibiting cellular cytotoxicity due to glycosylation and containing ganglioside GM2 binding antibody | Jun 17, 2010 | Issued |
Array
(
[id] => 6024284
[patent_doc_number] => 20110052610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'ANTIBODY COMPOSITION EXHIBITING CELLULAR CYTOTOXICTY DUE TO GLYCOSYLATION'
[patent_app_type] => utility
[patent_app_number] => 12/818363
[patent_app_country] => US
[patent_app_date] => 2010-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 77382
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20110052610.pdf
[firstpage_image] =>[orig_patent_app_number] => 12818363
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/818363 | Anti-il-5 antibody composition exhibiting cellular cytotoxicity due to glycosylation | Jun 17, 2010 | Issued |